References
- Goff, D. C. & Coyle, J. T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:1367-1377 (2001) https://doi.org/10.1176/appi.ajp.158.9.1367
- Coyle, J. T. & Tsai, G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol 59:491-515 (2004) https://doi.org/10.1016/S0074-7742(04)59019-0
- McCullumsmith, R. E., Clinton, S. M. & Meador- Woodruff, J. H. Schizophrenia as a disorder of neuroplasticity. Int Rev Neurobiol 59:19-45 (2004) https://doi.org/10.1016/S0074-7742(04)59002-5
- Carlsson, A. et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260 (2001) https://doi.org/10.1146/annurev.pharmtox.41.1.237
- Laruelle, M. et al. Mechanism of action of antipsychotic drugs: from dopamine D 2 receptor antagonism to glutamate NMDA facilitation. Clin Ther 27:s16-s24 (2005) https://doi.org/10.1016/j.clinthera.2005.07.017
- Javitt, D. C. Gultamate and schizophrenia: phencyclidine, N-methyl-D-Aspartate receptors, and dopamineglutamate interactions. Int Rev Neurobiol 78:69-108 (2007) https://doi.org/10.1016/S0074-7742(06)78003-5
- Ellison, G. The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev 20:250-267 (1995) https://doi.org/10.1016/0165-0173(94)00014-G
- Javitt, D. C. & Zukin, S. R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiat 148:1301-1308 (1991) https://doi.org/10.1176/ajp.148.10.1301
- Paulson, L. et al. Comparative proteome analysis of thalamus in MK-801-treated rats. Proteomics 4:819-825 (2004) https://doi.org/10.1002/pmic.200300622
- Marcotte, E. R., Pearson, D. M. & Srivastava, L. K. Animal models of schizophrenia: a critical review. J Psychiatry Neurosci 26:395-410 (2001)
- Farber, N. B., Foster, J., Duhan, N. L. & Olney, J. W. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr Res 21:33-37 (1996) https://doi.org/10.1016/0920-9964(96)00024-2
- Carlsson, M. & Svensson, A. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacol Biochem Behav 36:45-50 (1990) https://doi.org/10.1016/0091-3057(90)90123-Y
- al-Amin, H. A. & Schwarzkopf, S. B. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia. Biol Psychiatry 40:744-754 (1996) https://doi.org/10.1016/0006-3223(95)00485-8
- Matsuoka, T. et al. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: Therapeutic implications for schizophrenia. Brain Research 1053: 131-136 (2005) https://doi.org/10.1016/j.brainres.2005.06.035
- Wolf, M. E. & Khansa, M. R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168 (1991) https://doi.org/10.1016/0006-8993(91)91202-C
- Sams-Dodd, F. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6:55-65 (1995)
- Li, Z., Kim, C. H., Ichikawa, J. & Meltzer, H. Y. Effect of repeated administration of phencyclidine on spatial performance in an eight arm radial maze with delay in rats and mice. Pharmacol Biochem Behav 75:335-340 (2003) https://doi.org/10.1016/S0091-3057(03)00085-6
- Schulz, B., Fendt, M., Pedersen, V. & Koch, M. Sensitization of prepulse inhibition deficits by repeated administration of dizocilpine. Psychopharmacol (Berlin) 156:177-181 (2001) https://doi.org/10.1007/s002130100776
- Frankenburg, F. R. Choices in antipsychotic therapy in schizophrenia. Harv Rev Psychiat 6:241-249 (1999) https://doi.org/10.3109/10673229909000336
- Kane, J. M., Leucht, S., Carpenter, D. & Docherty, J. P. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiat 64:5-19 (2003) https://doi.org/10.4088/JCP.v64n0301
- Hyman, S. E. & Nestler, E. J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiat 153:151-162 (1996) https://doi.org/10.1176/ajp.153.2.151
- Dragunow, M. et al. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37:287-294 (1990) https://doi.org/10.1016/0306-4522(90)90399-O
- Konradi, C. & Heckers, S. Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50:729-742 (2001) https://doi.org/10.1016/S0006-3223(01)01267-7
- MacDonald, M. L., Eaton, M. E., Dudman, J. T. & Konradi, C. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiat 57:1041-1051 (2005) https://doi.org/10.1016/j.biopsych.2005.01.022
- Fatemi, S. H. et al. Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique. Neuropsychopharmacol 31:1888-1899 (2006) https://doi.org/10.1038/sj.npp.1301002
- Bymaster, F. P. et al. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J Clin Psychiat 58:28S-36S (1997)
- Tarazi, F. I., Baldessarini, R. J., Kula, N. S. & Zhang, K. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: Implications for antipsychotic drug treatment. J Pharmacol Exp Ther 306:1145-1151 (2003) https://doi.org/10.1124/jpet.103.052597
- Marcotte, E. R., Srivastava, L. K. & Quirion, R. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol Ther 100:63-74 (2003) https://doi.org/10.1016/S0163-7258(03)00086-X
- Gardonic, F. & Luca, M. D. New targets for pharmaceutical intervention in the glutamatergic synapse. Eur J Pharmacol 545:2-10 (2006) https://doi.org/10.1016/j.ejphar.2006.06.022
- Wang, J. Q., Fibuch, E. E. & Mao, L. Regulation of mitogen-activated protein kinases by glutamate receptors. J Neurochem 100:1-11 (2007) https://doi.org/10.1111/j.1471-4159.2006.04208.x
- Svensson, T. H. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Rev 31:320-329 (2000) https://doi.org/10.1016/S0165-0173(99)00048-X
- Chong, V. Z., Young, L. T. & Mishra, R. K. cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. J Neurochem 82: 1533-1539 (2002) https://doi.org/10.1046/j.1471-4159.2002.01104.x
- Thomas, E. A. et al. Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism- related proteins. Mol Psychiat 8:983-993 (2003) https://doi.org/10.1038/sj.mp.4001425
- Liu, C., Gilmont, R. R., Benndorf, R. & Welsh, M. J. Identification and characterization of a novel protein from sertoli cells, PASS1, that associates with mammalian small stress protein hsp27. J Biol Chem 275: 18724-18731 (2000) https://doi.org/10.1074/jbc.M001981200
- Whitlock, N. A. et al. Heat shock protein 27 delays Ca2_-induced cell death in a caspase-dependent and - independent manner in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 46:1085-1091 (2005) https://doi.org/10.1167/iovs.04-0042
- Arion, D. et al. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiat 62:711-721 (2007) https://doi.org/10.1016/j.biopsych.2006.12.021
- Liou, Y. J. et al. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia. Pharmacogenet Genomics 16:151-157 (2006)
- Infante, C. et al. Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: effects of competitive and uncompetitive N-methyl- D-aspartate antagonists. Arthritis Res Ther 9:R53-R60 (2007) https://doi.org/10.1186/ar2208
- Khan, S., Milot, M., Lecompte-Collin, J. & Plamondon, H. Time-dependent changes in CRH concentrations and release in discrete brain regions following global ischemia: effects of MK-801 pretreatment. Brain Res 1016:48-57 (2004) https://doi.org/10.1016/j.brainres.2004.04.062
- Yuan, J., Jia, R. & Bao, Y. Aldosterone up-regulates production of plasminogen activator inhibitor-1 by renal mesangial cells. J Biochem Mol Biol 40:180-188 (2007) https://doi.org/10.5483/BMBRep.2007.40.2.180
- Kuhl, N. M., Hoekstra, D., Vries, H. D. & Keyser, J. D. Insulin-like growth factor-binding protein 6 inhibits survival and differentiation of rat oligodendrocyte precursor cells. Glia 44:91-101 (2003) https://doi.org/10.1002/glia.10263
-
Ghaleb, A. M. et al. Kruppel-like factor 4 exhibits antiapoptotic activity following
$\gamma$ -radiation-induced DNA damage. Oncogene 26:2365-2373 (2007) https://doi.org/10.1038/sj.onc.1210022 - Wang, Z. N. et al. Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett 453:135-139 (1999) https://doi.org/10.1016/S0014-5793(99)00708-5
- Hedbacker, K., Hong, S. P. & Carlson, M. Pak1 protein kinase regulates activation and nuclear localization of Snf1-Gal83 protein kinase. Mol Cell Biol 24: 8255-8263 (2004) https://doi.org/10.1128/MCB.24.18.8255-8263.2004
- Ogura, Y. T. et al. Postnatal changes in gene expression of retinal dehydrogenase and retinoid receptors in liver of rats. Life Sci 74:1519-1528 (2004) https://doi.org/10.1016/j.lfs.2003.08.020
- Mitsuia, S., Yamaguchib, N., Osakoa, Y. & Yuria, K. Enzymatic properties and localization of motopsin (PRSS12), a protease whose absence causes mental retardation. Brain Res 1136:1-12 (2007) https://doi.org/10.1016/j.brainres.2006.11.094
- Kamphuis, W., Dijk, F., van Soest, S. & Bergen, A. A. B. Global gene expression profiling of ischemic preconditioning in the rat retina. Molecular Vision 13:1020-1030 (2007)
- Fumagalli, F. et al. Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity. J Neurosci Res 72:622-628 (2003) https://doi.org/10.1002/jnr.10609
- Kusumi, I. et al. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain. J Neural Transm 107:295-302 (2000) https://doi.org/10.1007/s007020050024
- Chang, C. C. et al. Methimazole alleviates hepatic encephalopathy in bile-duct ligated cirrhotic rats. J Chin Med Assoc 69:563-568 (2006) https://doi.org/10.1016/S1726-4901(09)70330-2